Despite HOB Biotech's falling earnings and price, its P/E still surpasses the market. Investors remain bullish, unwilling to sell their stock. Yet, if recent earnings trends persist, shareholders and potential investors could face significant risk and overpayment.
Hob Biotech Group Corp., Ltd Stock Forum
No comment yet